Pt Kimia Farma Persero Tbk operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pt Kimia Farma Persero Tbk with three other
pharmaceutical manufacturers in Asia:
Shenzhen Hepalink Pharmaceutical Company Limited
sales of 1.76 billion Chinese Renmimbi [US$283.05 million]
of which 87%
was General Level Heparin Sodium API),
Shanghai Shyndec Pharmaceutical Co Ltd
(2.01 billion Chinese Renmimbi [US$322.45 million]
of which 74%
was Medicine Manufacturing (Industry)), and
PKU HealthCare Corp Ltd
based in China
(1.95 billion Chinese Renmimbi [US$312.97 million]
of which 54%
was Sale of Medicinal Materials).
Pt Kimia Farma Persero Tbk reported sales of 3.73 trillion Indonesian Rupiahs (US$327.12 million)
December of 2012.
increase of 7.3%
versus 2011, when the company's sales were 3.48 trillion Indonesian Rupiahs.
Sales at Pt Kimia Farma Persero Tbk have increased during each of the previous five years
(and since 2007, sales have increased a total of 58%).